Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
SPRY
#2141
ARS Pharmaceuticals, Inc. Common Stock
9.297
0
-1.62%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-1.62%
Monatliche Änderung
-11.46%
6 month change
+0.94%
Jahresänderung
+0.94%
Vorheriger Schlusskurs
9.450
0
Open
9.280
0
Bid
Ask
Low
9.280
0
High
9.297
0
Volumen
101
Märkte
Aktien
Gesundheitswesen
SPRY
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
97.19 M
98.12 M
98.21 M
98.83 M
98.85 M
—
Valuation ratios
Enterprise value
1.37 B
984.35 M
1.2 B
1.67 B
933.87 M
4.79 B
Price to earnings ratio
-28.43
131.88
-78.63
-35.61
-12.41
5.23
Price to sales ratio
547.66
12.12
13.2
15.75
7.1
48.16
Price to cash flow ratio
30.42
79.73
25.46
21.24
8.75
135.18
Price to book ratio
1.6
4.21
1.38
1.97
1.21
8.76
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
-0.1
0.1
0.14
0.14
0.29
Return on equity %
0.1
-0.13
0.15
0.23
0.35
0.6
Return on invested capital %
—
-1 518.95
—
—
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
1 051.64
-54.51
466.29
302.95
163.66
878.38
EBITDA margin %
—
—
—
—
—
—
Net margin %
924.95
-39.2
425.69
285.57
157.38
829.44
Liquidity ratios
Quick ratio
12.52
14.04
10.74
5.69
6.24
36.7
Current ratio
12.56
14.26
11
6.17
6.66
38.09
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0.3
0.02
0.05
0.09
0.47
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
0.26
—
Long term debt to total equity ratio
—
—
—
—
0.65
—
Per share metrics
Operating cash flow per share
0.15
-0.15
0.42
0.4
0.48
1.15
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.11
3.07
2.81
2.44
2.92
11.24
Net current asset value per share
2.15
3.26
3.1
2.86
3.43
12.65
Tangible book value per share
1.99
2.44
2.26
1.82
1.35
7.87
Working capital per share
1.98
3.04
2.82
2.4
2.91
11.17
Book value per share
2.07
2.51
2.34
1.96
1.49
8.29
Nachrichten
ARS Pharmaceuticals Stock: Climbing Neffy Sales Global Expansion Re-Rate (NASDAQ:SPRY)
What's Going On With ARS Pharmaceuticals Stock Friday? - ARS Pharmaceuticals (NASDAQ:SPRY)
Why Is Aquestive Therapeutics Stock Falling Today? - Aquestive Therapeutics (NASDAQ:AQST)
ARS Pharmaceuticals: Adrenalin-Nasenspray erhält Marktzulassung in China
China approves first community use epinephrine nasal spray for allergies
ARS Pharma: CBO verkauft Aktien im Wert von 1,47 Mio. US-Dollar
ARS Pharma: COO verkauft Aktienpaket im Wert von 190.000 $
ARS Pharma CBO Chakma sells shares worth $1.47 million
Dorsey, ARS Pharma COO, sells $190k in SPRY stock
ARS Pharmaceuticals, Inc. (SPRY) Q3 2025 Earnings Call Transcript
ARS Pharmaceuticals: Starke Q3-Zahlen und bestätigtes Kaufvotum treiben Aktie an
William Blair bestätigt "Outperform"-Rating für ARS Pharmaceuticals nach Neffy-Daten